Politician trade (House)

Pfizer (PFE): Rep. Greg Landsman (OH01) disclosed a sale $1K–$15K

Rep. Greg Landsman (OH01) disclosed a sale of Pfizer in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
30 days
Disclosure lag
Traded
Oct 15, 2024
Disclosed
Nov 14, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 1, 2023CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  2. Aug 1, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  3. Aug 6, 2024CongressDisclosed sale of PFE — reported range $15,001 - $50,000
  4. Aug 9, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  5. Sep 12, 2024FDAFDA drug approval: Mektovi
  6. Sep 12, 2024FDAFDA drug approval: Braftovi
  7. Oct 11, 2024FDAFDA drug approval: Hympavzi
  8. Oct 15, 2024 · this disclosureCongressDisclosed sale of PFE — reported range $1,001 - $15,000

What came next

  1. Oct 15, 2024FDAFDA drug approval: Fragmin
  2. Oct 21, 2024CongressDisclosed purchase of PFE — reported range $15,001 - $50,000
  3. Oct 30, 2024InsiderDirector purchased ~$28K of PFE shares in the open market
  4. Dec 20, 2024FDAFDA drug approval: Braftovi
  5. Dec 20, 2024Layoff notice · Heights Union East, 2002 N. 6th Floor, TAMPA, FL, 33602Layoff notice filed in FL: 62 employees
  6. Jan 15, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
  7. Jan 24, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
  8. Jan 31, 2025FDAFDA drug approval: Paxlovid (Copackaged)
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Pfizer

OQRO holds no insider, Congress, fund or contract record for Pfizer dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

Other recent filings by Rep. Greg Landsman (OH01)

The full history of Rep. Greg Landsman (OH01) is on the profile page.

How this filing works

Explore the data

Other disclosures at Pfizer

Everything OQRO holds on this company is on its PFE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data